Europe Cannabidiol Market size surpassed USD 1.9 billion in 2020 and is estimated to witness over 33.5% CAGR from 2021 to 2027.
The CBD market in Europe significantly relies on the regulatory authorities for its legalization, licensing, and monitoring level. The legal status of cannabidiol-based products varies by individual countries. The approval process of authorities has been biased towards the medicinal and related applications, limiting the recreational use.
With an increasing potential in the market, the Court of Justice of the European Union in November 2020 stated that CBD is not a narcotic substance. This move allows CBD products to be sold freely across the countries of European Union. The ruling also laid a smooth regulatory pathway for the legal use of cannabidiol. This ruling reinforces the confidence of CBD-based products manufacturers and fuels the market growth.
Europe Cannabidiol (CBD) Market, 2021 & 2027 (USD Mn)
Get more details on this report - Request Free Sample PDF
Further, as CBD is proven for its therapeutic benefits, considerable focus remains on further research and development opportunities. With an increasing consumer awareness and regulatory guidance for the users to identify different products, the Europe market is expected to witness sizeable demand in the coming years.
Europe Market, By Product
The oil segment is pegged at over USD 450 million in 2020. A substantial proportion of the market is accounted by CBD oils and one of the prominent reasons for this is the significant penetration of oils as compared to other product types. The oils segment in the market can be termed as an ‘established and mature segment’ of the market, witnessing a stable demand across countries. With other product types being relatively newer as different suppliers adopt different administration routes of CBD, these are anticipated to create lucrative opportunities.
Europe Market, By Application
The chronic pain segment is noted to account for over 35% market share in 2020. As the CBD market in Europe is relatively in its infancy, it is noted that a larger proportion of the population opts for CBD-based medications for pain relief purposes. This can be attributed to the prevalence of chronic pain in the region, as well as to the increasing consumer awareness over the benefits of CBD-derived products for the treatment of pain.
Europe Market, By Route of Administration
The topical route of administration segment will observe around 33.1% growth rate during the forecast period. An increasing interest is observed in the cosmetic benefits of CBD-based products with the introduction of creams and roll-on, among others. As the limelight remains upon treating dry skin, topical route of administration is also gaining traction for its anti-inflammatory effects. With several formulations with essential oils, CBD-based topical route of administration is noted as one of the key growth areas of the market.
Europe Market, By Source
Hemp-derived cannabidiol is largely unrestricted in most of the countries in Europe owing to its negligible THC content. The segment is expected to cross market value of USD 18 billion by 2027 while being the primary source of CBD in Europe. The regulatory framework predominantly influences such a consumption pattern and is set to maintain a similar stance in the coming years.
Europe Market, By Distribution Channel
The online segment held over 45% Europe cannabidiol (CBD) market share in 2020. In countries where CBD is legal, online sales have gained traction due to wide availability, relatively lower prices, and a large variety of alternative products. Online channel also offers the patients convenience of timely home delivery.
Europe Market, By Country
Germany cannabidiol market is one of the largest markets in Europe with sales peaking at USD 500 million in 2020. With a fairly supportive regulatory stance of authorities in Germany, over-the-counter (OTC) sales largely fuel the market demand in Germany. The country continues to support CBD manufacturers with products containing less than 0.2% THC.
Competitive Industry Landscape
Prominent Europe CBD market players are CBD One Ltd, Formula Swiss AG, Green Brothers Switzerland SA, HemPoland sp. z o.o. and MH medical hemp GmbH, among others. Companies engage in different organic and inorganic growth strategies to establish and strengthen their market presence in the region.